Application of Simethicone in Esophagogastroscopy
Launched by AFFILIATED HOSPITAL TO ACADEMY OF MILITARY MEDICAL SCIENCES · Dec 13, 2018
Trial Information
Current as of April 28, 2025
Completed
Keywords
ClinConnect Summary
Esophagogastroscopy can enable the direct examination of the esophageal and gastric mucosal lesions, which has been widely applied in clinical practice. However, during the examination, too much water, foam or residues in the stomach will not only increase the procedure time and the misdiagnosis rate, but also decrease the patients' tolerance, for more efforts should be made to deal with the excessive water, foam or residues in order to obtain a clear view of the mucosa. Simethicone is also called poly-dimethylsiloxane, which can be used to remove the foam and water. Although simethicone ha...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Above 18 years old patients
- • Who agree to participate in the study
- • Patients with the indications for gastroduodenoscopy
- Exclusion Criteria:
- • Patients, who were receiving nonsteroidal anti-inflammatory drugs, pump inhibitors (PPI) or antibiotics in the last 3 weeks.
- • Severe uncontrolled coagulopathy
- • Prior history of gastric surgery.
- • Pregnancy and lactation
About Affiliated Hospital To Academy Of Military Medical Sciences
The Affiliated Hospital to the Academy of Military Medical Sciences is a leading clinical trial sponsor dedicated to advancing medical research and improving patient care. With a strong emphasis on innovation and excellence, the institution combines military medical expertise with cutting-edge research methodologies. It collaborates closely with academic and healthcare professionals to conduct rigorous clinical trials across various therapeutic areas, ensuring compliance with ethical standards and regulatory requirements. The hospital is committed to fostering a culture of scientific inquiry and delivering impactful healthcare solutions that benefit both military and civilian populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Yan Liu
Principal Investigator
PLA General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials